The cGAS-STING pathway plays dual roles in promoting both anti-tumor and pro-tumor immunity, which can vary depending on the cancer type and stage (Khoo & Chen, 2018; Ng et al., 2018; Zheng et al., 2020). This evidence concerns the gene STING1 and neoplasm.